Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
62 /100
COMPONENT-LIMITED
Score updated Oct 24, 2026

GRTXD — Galera Therapeutics, Inc. Dilution Risk Tracker

Track GRTXD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GRTXD — Get alerts when the score changes →

As of October 24, 2026, Galera Therapeutics, Inc. (GRTXD) has a DilutionWatch DilutionScore of 62/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Galera Therapeutics, Inc. has 160.43M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
85
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 20%
💰 Capital Raise model 35%
• Low cash runway: 3 months remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (62/100)
🔔 Track GRTXD — Get forecast alerts →

Market Data

Market CapN/A
Shares Outstanding160.43M
FloatN/A
Cash$5.50M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore62/100DilutionWatch score record
Shares Outstanding160.43MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market CapNot availableMarket data cache
Cash Runway3.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

GRTXD SEC Filing Activity — Last 12 Months

Shares outstanding reported by GRTXD on the cover page of its latest 10-K/10-Q: 160.43M as of May 12, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for GRTXD in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
EFFECTSEC declared a registration effective1Aug 10, 2026
8-Kcurrent report (material event)1Aug 03, 2026
SC 13G/Aamended passive >5% holder filing1Aug 14, 2026
3initial insider ownership4Aug 05, 2026

Institutional Holdings

Institutional data not yet available.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-19
xbrl XBRL CONVERTIBLE 2026-03-19
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GRTXD Dilution Snapshot

Galera Therapeutics, Inc. (GRTXD) has a DilutionScore of 62/100, rated High dilution risk. Score date: October 24, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GRTXD's DilutionScore is currently 62/100 (High risk), with 4 score changes tracked over 89 days. The score deteriorated from 65/100 (High risk).

Period Score Risk Level Duration
Oct 05 – Oct 24, 202662/100HIGH20 days
Sep 28 – Oct 04, 202665/100HIGH7 days
Aug 22 – Sep 27, 202660/100HIGH37 days
Aug 14 – Aug 21, 202656/100HIGH7 days
Jul 27 – Aug 13, 202650/100MEDIUM18 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track GRTXD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GRTXD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GRTXD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,550+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note